Xun Yuan1, Andreas Mitsis1, Mohammed Ghonem1, Ilias Iakovakis2, Christoph A Nienaber1. 1. Cardiology and Aortic Centre, Royal Brompton & Harefield NHS Foundation Trust and Imperial College, London, UK. 2. Cardiac Surgery Department, Royal Brompton & Harefield NHS Foundation Trust and Imperial College, London, UK.
Abstract
BACKGROUND: Type B aortic dissection is a life-threatening acute aortic condition often with acute ischemic signs or symptoms. With initial management focusing on alleviating malperfusion and pain, and avoiding propagation of dissection or rupture both systolic blood and pulse pressure should be reduced initially by an aggressive medical approach. In the setting of persistent signs of complications endovascular strategies have replaced open surgery and led to a fourfold increase in early survival and better long-term outcomes. METHODS: An electronic health database search was performed on articles published between January 2006 and July 2017. Publications were included in this review if (I) the index aortic pathology was type B aortic (distal) dissection; (II) when medical management, open surgical replacement or thoracic endovascular aortic repair were among those options; (III) when at least one of all basic outcome criteria such as survival, spinal cord ischemia and cerebrovascular accident was reported; (IV) when ≥15 serial patients were included. A total of 62 studies were eligible and analysed. RESULTS: Our manuscript has summarized data collected over 12 years on management specific outcomes in the setting of distal aortic dissection and provides an up-to-date interpretation of the published evidence. For complicated cases, treated acutely, the 30-day or in-hospital mortality was 7.3% when managed by endovascular means, whereas the pooled rate for 30-day or in-hospital mortality was 19.0% when subjected to open repair. For acute uncomplicated type B dissection usually treated with blood pressure lowering medications, the pooled 30-day or in-hospital mortality rate was 2.4%. Survival rates at 5 years averaged at 60% (40% mortality). Freedom from any aortic event ranged from 34.0% to 83.9%, underlining an inherent risk of progression and late complications. For chronic complicated type B dissection, the rates of stroke, paraplegia and operative mortality following endovascular repair ranged from 5% to 13%, 2% to 13% and 2 to 13%, respectively, while 5-year survival rates after open repair ranged from 60% to 90%. In chronic uncomplicated type B dissection almost 90% of patients survive initial hospitalization and were subjected to medical management with a 5-year survival of 50-80%. However, up to 20-55% of medically treated patients develop aneurysmal degeneration after 5 years with an unknown risk of rupture. CONCLUSIONS: Currently, the less invasive strategy of endovascular repair (as compared to open surgery) provides improved 30-day or in-hospital survival in the setting of complicated acute type B aortic dissection and may seek broad application. Open surgical aortic reconstruction should be left to experienced aortic centres if endovascular management is not an option.
BACKGROUND: Type B aortic dissection is a life-threatening acute aortic condition often with acute ischemic signs or symptoms. With initial management focusing on alleviating malperfusion and pain, and avoiding propagation of dissection or rupture both systolic blood and pulse pressure should be reduced initially by an aggressive medical approach. In the setting of persistent signs of complications endovascular strategies have replaced open surgery and led to a fourfold increase in early survival and better long-term outcomes. METHODS: An electronic health database search was performed on articles published between January 2006 and July 2017. Publications were included in this review if (I) the index aortic pathology was type B aortic (distal) dissection; (II) when medical management, open surgical replacement or thoracic endovascular aortic repair were among those options; (III) when at least one of all basic outcome criteria such as survival, spinal cord ischemia and cerebrovascular accident was reported; (IV) when ≥15 serial patients were included. A total of 62 studies were eligible and analysed. RESULTS: Our manuscript has summarized data collected over 12 years on management specific outcomes in the setting of distal aortic dissection and provides an up-to-date interpretation of the published evidence. For complicated cases, treated acutely, the 30-day or in-hospital mortality was 7.3% when managed by endovascular means, whereas the pooled rate for 30-day or in-hospital mortality was 19.0% when subjected to open repair. For acute uncomplicated type B dissection usually treated with blood pressure lowering medications, the pooled 30-day or in-hospital mortality rate was 2.4%. Survival rates at 5 years averaged at 60% (40% mortality). Freedom from any aortic event ranged from 34.0% to 83.9%, underlining an inherent risk of progression and late complications. For chronic complicated type B dissection, the rates of stroke, paraplegia and operative mortality following endovascular repair ranged from 5% to 13%, 2% to 13% and 2 to 13%, respectively, while 5-year survival rates after open repair ranged from 60% to 90%. In chronic uncomplicated type B dissection almost 90% of patients survive initial hospitalization and were subjected to medical management with a 5-year survival of 50-80%. However, up to 20-55% of medically treated patients develop aneurysmal degeneration after 5 years with an unknown risk of rupture. CONCLUSIONS: Currently, the less invasive strategy of endovascular repair (as compared to open surgery) provides improved 30-day or in-hospital survival in the setting of complicated acute type B aortic dissection and may seek broad application. Open surgical aortic reconstruction should be left to experienced aortic centres if endovascular management is not an option.
Entities:
Keywords:
Distal aortic dissection; endovascular treatment; literature review; medical therapy; open surgery
Authors: Santi Trimarchi; Christoph A Nienaber; Vincenzo Rampoldi; Truls Myrmel; Toru Suzuki; Eduardo Bossone; Valerio Tolva; Michael G Deeb; Gilbert R Upchurch; Jeanna V Cooper; Jianming Fang; Eric M Isselbacher; Thoralf M Sundt; Kim A Eagle Journal: Circulation Date: 2006-07-04 Impact factor: 29.690
Authors: Anthony L Estrera; Charles C Miller; Jennifer Goodrick; Eyal E Porat; Paul E Achouh; Jayesh Dhareshwar; Riad Meada; Ali Azizzadeh; Hazim J Safi Journal: Ann Thorac Surg Date: 2007-02 Impact factor: 4.330
Authors: J Brunkwall; P Kasprzak; E Verhoeven; R Heijmen; P Taylor; P Alric; L Canaud; M Janotta; D Raithel; W Malina; Ti Resch; H-H Eckstein; S Ockert; T Larzon; F Carlsson; H Schumacher; S Classen; P Schaub; J Lammer; L Lönn; R E Clough; V Rampoldi; S Trimarchi; J-N Fabiani; D Böckler; D Kotelis; D Böckler; D Kotelis; H von Tenng-Kobligk; N Mangialardi; S Ronchey; G Dialetto; V Matoussevitch Journal: Eur J Vasc Endovasc Surg Date: 2014-06-22 Impact factor: 7.069
Authors: Raimund Erbel; Victor Aboyans; Catherine Boileau; Eduardo Bossone; Roberto Di Bartolomeo; Holger Eggebrecht; Arturo Evangelista; Volkmar Falk; Herbert Frank; Oliver Gaemperli; Martin Grabenwöger; Axel Haverich; Bernard Iung; Athanasios John Manolis; Folkert Meijboom; Christoph A Nienaber; Marco Roffi; Hervé Rousseau; Udo Sechtem; Per Anton Sirnes; Regula S von Allmen; Christiaan J M Vrints Journal: Eur Heart J Date: 2014-08-29 Impact factor: 29.983
Authors: Woong Chol Kang; Roy K Greenberg; Tara M Mastracci; Matthew J Eagleton; Adrian V Hernandez; Akshat C Pujara; Eric E Roselli Journal: J Thorac Cardiovasc Surg Date: 2011-05-05 Impact factor: 5.209
Authors: I Chemelli-Steingruber; A Chemelli; A Strasak; B Hugl; R Hiemetzberger; W Jaschke; B Glodny; B V Czermak Journal: Eur J Radiol Date: 2008-11-08 Impact factor: 3.528
Authors: Julio A Rodriguez; Dawn M Olsen; Leonardo Lucas; Grayson Wheatley; Venkatesh Ramaiah; Edward B Diethrich Journal: J Vasc Surg Date: 2008-04-28 Impact factor: 4.268
Authors: Michal Nozdrzykowski; Christian D Etz; Maximilian Luehr; Jens Garbade; Martin Misfeld; Michael A Borger; Friedrich-Wilhelm Mohr Journal: Eur J Cardiothorac Surg Date: 2013-06-12 Impact factor: 4.191
Authors: Lars G Svensson; Nicholas T Kouchoukos; D Craig Miller; Joseph E Bavaria; Joseph S Coselli; Michael A Curi; Holger Eggebrecht; John A Elefteriades; Raimund Erbel; Thomas G Gleason; Bruce W Lytle; R Scott Mitchell; Christoph A Nienaber; Eric E Roselli; Hazim J Safi; Richard J Shemin; Gregorio A Sicard; Thoralf M Sundt; Wilson Y Szeto; Grayson H Wheatley Journal: Ann Thorac Surg Date: 2008-01 Impact factor: 4.330